Alvotech

AI-generated fair value estimate for this company.

Method: Black-Scholes call option: underlying price S=$5.75 (Alvotech common close, 9/25/2026); strike K=$11.50 (per the 424B3 filing); time to expiration T=0.72 years (to 6/15/2027); risk-free rate r=4%; volatility sigma=65% (typical for a biotech); resulting call value approximately $0.24

Reasoning: Alvotech is a real operating biosimilars company (TTM revenue of $494.6M, market cap ~$2.05B) trading about 50% below the warrant's strike with under nine months remaining, so the warrant's value is almost pure time value and can be rigorously estimated with a standard option-pricing model on real, current inputs.